Why the Aurinia Pharmaceuticals stock is collapsing today

What happened Actions of Aurinia Pharmaceuticals (NASDAQ: AUPH), a biotechnology at the start of the commercial phase, are down 17% in afternoon trading Thursday afternoon. Biotech stock is plummeting in response to the company’s first quarter 2021 earnings report released after the closing bell today. So what Investors appear to …

Read More »